to scale back the chance of major cardiovascular functions for example coronary heart assault, stroke, or Loss of life in adults with kind 2 diabetes with identified heart problems to reduce the chance of kidney condition worsening, kidney failure (conclusion-stage kidney sickness), and Dying as